Dendritic-cell therapy after non-myeloablative stem-cell transplantation for renal-cell carcinoma
- 31 December 2004
- journal article
- case report
- Published by Elsevier in The Lancet Oncology
- Vol. 5 (12) , 750-752
- https://doi.org/10.1016/s1470-2045(04)01652-3
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Allogeneic Stem-Cell Transplantation of Renal Cell Cancer After Nonmyeloablative Chemotherapy: Feasibility, Engraftment, and Clinical ResultsJournal of Clinical Oncology, 2002
- The use of dendritic cells in cancer therapyThe Lancet Oncology, 2001
- Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine, 2000